Ventilation During Cardiopulmonary Bypass: Impact on Cytokine Response and Cardiopulmonary Function

Annals of Thoracic Surgery

Volumn 85, Issue 1, 2008, Pages 154-162

  Ng, Calvin S H ^a   Arifi, Ahmed A ^a   Wan, Song ^a   Ho, Anthony M H ^a   Wan, Innes Y P ^a   Wong, Eric M C ^a   Yim, Anthony P C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 8; THROMBOXANE B2; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ANALYTICAL PARAMETERS; AORTA CLAMPING; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CARDIOPULMONARY FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; INFLAMMATION; LUNG COMPLIANCE; LUNG LAVAGE; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; SYSTEMIC VASCULAR RESISTANCE; VENTILATED PATIENT;

CARDIOPULMONARY BYPASS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HEMODYNAMICS; HUMANS; INFLAMMATION MEDIATORS; INTRAOPERATIVE CARE; MALE; MONITORING, INTRAOPERATIVE; MULTIVARIATE ANALYSIS; OXYGEN; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 37249082962     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.07.068     Document Type: Article

References (28)

1. Wan S., LeClerc J.L., and Vincent J.L. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112 (1997) 676-692
2. Ng C.S., Wan S., Yim A.P., and Arifi A.A. Pulmonary dysfunction after cardiac surgery. Chest 121 (2002) 1269-1277
3. Wan S., Izzat M.B., Lee T.W., Wan I.Y., Tang N.L., and Yim A.P. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg 68 (1999) 52-57
4. Wan S., Yim A.P., Ng C.S., and Arifi A.A. Systematic organ protection in coronary artery surgery with or without cardiopulmonary bypass. J Cardiac Surg 17 (2002) 529-535
5. Magnusson L., Zemgulis V., Tenling A., et al. Use of a vital capacity manoeuver to prevent atelectasis after cardiopulmonary bypass. Anesthesiology 88 (1998) 134-142
6. Magnusson L., Wicky S., Tyden H., and Hedenstierna G. Repeated vital capacity manoeuvres after cardiopulmonary bypass effects on lung function in a pig model. Br J Anaesth 80 (1998) 682-684
7. Ng C.S.H., Wan S., Arifi A.A., and Yim A.P.C. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today 36 (2006) 205-214
8. Serraf A., Robotin M., Bonnet N., et al. Alteration of the neonatal pulmonary physiology after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 114 (1997) 1061-1069
9. Friedman M., Sellke F.W., Wang S.Y., Weintraub R.M., and Johnson R.G. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation 90 (1994) II262-II268
10. de Perrot M., Liu M., Waddell T.K., and Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167 (2003) 490-511
11. Bouadma L., Schortgen F., Ricard J.D., Martet G., Dreyfuss D., and Saumon G. Ventilation strategy affects cytokine release after mesenteric ischemia-reperfusion in rats. Crit Care Med 32 (2004) 1563-1569
12. Wan I.Y., Arifi A.A., Wan S., et al. Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study. J Thorac Cardiovasc Surg 127 (2004) 1624-1631
13. Wan S., Marchant A., DeSmet J.M., et al. Human cytokine response to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 111 (1996) 469-477
14. Wan S., LeClerc J.-L., and Vincent J.-L. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg 63 (1997) 269-276
15. Hennein H.A., Ebba H., Rodriquez J.L., et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108 (1994) 626-635
16. Wan S., DeSmet J.-M., Barvais L., Goldstein M., Vincent J.L., and LeClerc J.L. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112 (1996) 806-811
17. Liebold A., Keyl C., and Birnbaum D.E. The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. Eur J Cardiothorac Surg 15 (1999) 340-345
18. Ranieri V.M., Suter P.M., and Tortorella C. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome. JAMA 282 (1999) 54-61
19. Ng C.S., Arifi A.A., Wan I.Y., et al. Maintaining ventilation during cardiopulmonary bypass attenuates polymorphonuclear cell activation and may reduce pulmonary polymorphonuclear cell sequestration. J Card Surg 17 (2002) 570
20. Wan S., and Yim A.P.C. Cytokines in myocardial injury: impact on cardiac surgical approach. Eur J Cardiothorac Surg 16 suppl 1 (1999) S107-S111
21. Giomarelli P., Scolletta S., Borrelli E., and Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg 76 (2003) 117-123
22. Okada K., Fujita T., Minamoto K., Liao H., Naka Y., and Pinsky D.J. Potentiation of endogenous fibrinolysis and rescue from lung ischemia/reperfusion injury in interleukin (IL)-10-reconstituted IL-10 null mice. J Biol Chem 275 (2000) 21468-21476
23. Fischer S., de Perrot M., Liu M., et al. Interleukin 10 gene transfection of donor lungs ameliorates posttransplant cell death by a switch from cellular necrosis to apoptosis. J Thorac Cardiovasc Surg 126 (2003) 1174-1180
24. Massoudy P., Zahler S., Becker B.F., Braun S.L., Barankay A., and Meisner H. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest 119 (2001) 31-36
25. Wan S., LeClerc J.L., Schmartz D., et al. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am Heart J 133 (1997) 335-339
26. Mayers I., Hurst T., Puttagunta L., et al. Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. J Thorac Cardiovasc Surg 122 (2001) 746-752
27. Galley H.F., Macaulay G.D., and Webster N.R. Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and tumour necrosis factor α release during cardiopulmonary bypass. Anaesthesia 57 (2002) 659-662
28. Torii K., Iida K., Miyazaki Y., et al. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 155 (1997) 43-46